Advanced search
Publication Cover
Acta Oncologica Volume 46, 2007 - Issue 3
Journal homepage
1,043
Views
54
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Humoral immune response to MUC1 and to the Thomsen-Friedenreich (TF) glycotope in patients with gastric cancer: Relation to survival

O. Kurtenkov National Institute for Health Development, Hiiu 42, 11619, Tallinn, EstoniaCorrespondence[email protected]
,
K. Klaamas National Institute for Health Development, Hiiu 42, 11619, Tallinn, Estonia
,
S. Mensdorff-Pouilly Vrije Universiteit Medical Center, De Boeleaan 1117, 1081 HV, Amsterdam, The Netherlands
,
L. Miljukhina National Institute for Health Development, Hiiu 42, 11619, Tallinn, Estonia
,
L. Shljapnikova National Institute for Health Development, Hiiu 42, 11619, Tallinn, Estonia
&
V. Chužmarov North Estonian Regional Hospital, Hiiu 44, 11619, Tallinn, Estonia
Pages 316-323 | Received 15 May 2006, Published online: 08 Jul 2009

Citations (54)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (9)

Jacquelot N, Tellier J, Nutt Sl & Belz Gt. (2021) Tertiary lymphoid structures and B lymphocytes in cancer prognosis and response to immunotherapies. OncoImmunology 10:1.
Read now
C. Phanthunane, R. Wijers, M. de Herdt, T.P.M. Langeveld, S. Koljenovic, S. Dasgupta, S. Sleijfer, R. J. Baatenburg de Jong, J. Hardillo, H. E. Balcioglu & R. Debets. (2021) B-cell clusters at the invasive margin associate with longer survival in early-stage oral-tongue cancer patients. OncoImmunology 10:1.
Read now
Takashi Kimura & Olivera J. Finn. (2013) MUC1 immunotherapy is here to stay. Expert Opinion on Biological Therapy 13:1, pages 35-49.
Read now
Rachel Hevey & Chang-Chun Ling. (2012) Recent Advances In Developing Synthetic Carbohydrate-Based Vaccines For Cancer Immunotherapies. Future Medicinal Chemistry 4:4, pages 545-584.
Read now
Kerstin Järås & Karen Anderson. (2011) Autoantibodies in cancer: prognostic biomarkers and immune activation. Expert Review of Proteomics 8:5, pages 577-589.
Read now
EugeniyP. Smorodin, OlegA. Kurtenkov, BorisL. Sergeyev, JelenaS. Branovets, Jelena G. Izotova & AndreyA. Formanovsky. (2011) SPECIFICITY OF SERUM ANTI-Adi IgG ANTIBODIES FROM PATIENTS WITH GASTROINTESTINAL CANCER. Journal of Immunoassay and Immunochemistry 32:3, pages 170-190.
Read now
Richard E Beatson, Joyce Taylor-Papadimitriou & Joy M Burchell. (2010) Muc1 Immunotherapy. Immunotherapy 2:3, pages 305-327.
Read now
Kristel Kodar, Oleg Kurtenkov & Kersti Klaamas. (2009) The Thomsen-Friedenreich Antigen and αGal-specific Human IgG Glycoforms: Concanavalin A Reactivity and Relation to Survival of Cancer Patients. Immunological Investigations 38:8, pages 704-717.
Read now
K. Klaamas, O. Kurtenkov, S. von Mensdorff-Pouilly, L. Shljapnikova, L. Miljukhina, V. Brjalin & A. Lipping. (2007) Impact of Helicobacter pylori Infection on the Humoral Immune Response to MUC1 Peptide in Patients with Chronic Gastric Diseases and Gastric Cancer. Immunological Investigations 36:4, pages 371-386.
Read now

Articles from other publishers (45)

Samantha Marglous, Claire E. Brown, Vered Padler-Karavani, Richard D. Cummings & Jeffrey C. Gildersleeve. (2024) Serum antibody screening using glycan arrays. Chemical Society Reviews 53:5, pages 2603-2642.
Crossref
Anna Christina Dragon, Luca Marie Beermann, Melina Umland, Agnes Bonifacius, Chiara Malinconico, Louisa Ruhl, Patrik Kehler, Johanna Gellert, Lisa Weiß, Sarah Mayer-Hain, Katharina Zimmermann, Sebastian Riese, Felicitas Thol, Gernot Beutel, Britta Maecker-Kolhoff, Fumiichiro Yamamoto, Rainer Blasczyk, Axel Schambach, Michael Hust, Michael Hudecek & Britta Eiz-Vesper. (2023) CAR-Ts redirected against the Thomsen-Friedenreich antigen CD176 mediate specific elimination of malignant cells from leukemia and solid tumors. Frontiers in Immunology 14.
Crossref
Iwona Radziejewska. (2023) Galectin-3 and Epithelial MUC1 Mucin—Interactions Supporting Cancer Development. Cancers 15:10, pages 2680.
Crossref
Phei Er Saw & Erwei Song. 2023. Tumor Ecosystem. Tumor Ecosystem 51 76 .
Francesca Romana Delvecchio, Michelle R Goulart, Rachel Elizabeth Ann Fincham, Michele Bombadieri & Hemant M Kocher. (2022) B cells in pancreatic cancer stroma. World Journal of Gastroenterology 28:11, pages 1088-1101.
Crossref
Masaaki Ito, Yusuke Oji, Mayuko Adachi, Rin Imanishi, Shouq Alzaaqi, Takaki Hiwasa, Yoko Oshima, Satoshi Yajima, Takashi Suzuki, Tatsuki Nanami, Makoto Sumazaki, Fumiaki Shiratori, Kimihiko Funahashi, Haruo Sugiayama & Hideaki Shimada. (2022) Serum WT1‑271 IgM antibody as a novel diagnostic marker for Gastric Cancer. Molecular and Clinical Oncology 16:3.
Crossref
Chenlu Li, Jingjing Pan, Yinyan Jiang, Yan Yu, Zhenlin Jin & Xupeng Chen. (2022) Characteristics of the Immune Cell Infiltration Landscape in Gastric Cancer to Assistant Immunotherapy. Frontiers in Genetics 12.
Crossref
Eugeniy P. Smorodin. (2021) Prospects and Challenges of the Study of Anti-Glycan Antibodies and Microbiota for the Monitoring of Gastrointestinal Cancer. International Journal of Molecular Sciences 22:21, pages 11608.
Crossref
Inka Brockhausen & Jacob Melamed. (2021) Mucins as anti-cancer targets: perspectives of the glycobiologist. Glycoconjugate Journal 38:4, pages 459-474.
Crossref
Zena N. Willsmore, Robert J. Harris, Silvia Crescioli, Khuluud Hussein, Helen Kakkassery, Deepika Thapa, Anthony Cheung, Jitesh Chauhan, Heather J. Bax, Alicia Chenoweth, Roman Laddach, Gabriel Osborn, Alexa McCraw, Ricarda M. Hoffmann, Mano Nakamura, Jenny L. Geh, Alastair MacKenzie-Ross, Ciaran Healy, Sophia Tsoka, James F. Spicer, Sophie Papa, Linda Barber, Katie E. Lacy & Sophia N. Karagiannis. (2021) B Cells in Patients With Melanoma: Implications for Treatment With Checkpoint Inhibitor Antibodies. Frontiers in Immunology 11.
Crossref
Wolf Herman Fridman, Florent Petitprez, Maxime Meylan, Tom Wei-Wu Chen, Cheng-Ming Sun, Lubka T. Roumenina & Catherine Sautès-Fridman. (2021) B cells and cancer: To B or not to B?. Journal of Experimental Medicine 218:1.
Crossref
George V. Sharonov, Ekaterina O. Serebrovskaya, Diana V. Yuzhakova, Olga V. Britanova & Dmitriy M. Chudakov. (2020) B cells, plasma cells and antibody repertoires in the tumour microenvironment. Nature Reviews Immunology 20:5, pages 294-307.
Crossref
Oleg Kurtenkov. (2020) Profiling of Naturally Occurring Antibodies to the Thomsen-Friedenreich Antigen in Health and Cancer: The Diversity and Clinical Potential. BioMed Research International 2020, pages 1-12.
Crossref
Kristopher A. Kleski, Kevin R. Trabbic, Mengchao Shi, Jean-Paul Bourgault & Peter R. Andreana. (2020) Enhanced Immune Response Against the Thomsen-Friedenreich Tumor Antigen Using a Bivalent Entirely Carbohydrate Conjugate. Molecules 25:6, pages 1319.
Crossref
Yi-Wei Xu, Yu-Hui Peng, Li-Yan Xu, Jian-Jun Xie & En-Min Li. (2019) Autoantibodies: Potential clinical applications in early detection of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma. World Journal of Gastroenterology 25:34, pages 5049-5068.
Crossref
Oleg Kurtenkov, Kaire Innos, Boris Sergejev & Kersti Klaamas. (2018) The Thomsen-Friedenreich Antigen-Specific Antibody Signatures in Patients with Breast Cancer. BioMed Research International 2018, pages 1-8.
Crossref
Issam Makhoul, Mohammad Atiq, Ahmed Alwbari & Thomas Kieber-Emmons. (2018) Breast Cancer Immunotherapy: An Update. Breast Cancer: Basic and Clinical Research 12, pages 117822341877480.
Crossref
Chuanwei Yang, James L. Murray & Nuhad K. Ibrahim. 2018. Immunology. Immunology 225 240 .
Jing Wu, Xiaobo Li, Wuqi Song, Yong Fang, Li Yu, Siyuan Liu, Leonid P. Churilov & Fengmin Zhang. (2017) The roles and applications of autoantibodies in progression, diagnosis, treatment and prognosis of human malignant tumours. Autoimmunity Reviews 16:12, pages 1270-1281.
Crossref
Swetha Tati, John C. Fisk, Julia Abdullah, Loukia Karacosta, Taylor Chrisikos, Padraic Philbin, Susan Morey, Diala Ghazal, Fatma Zazala, Joseph Jessee, Sally Quataert, Stephen Koury, David Moreno, Jing Ying Eng, Vladislav V. Glinsky, Olga V. Glinskii, Muctarr Sesay, Anthony W. Gebhard, Karamveer Birthare, James R. Olson & Kate Rittenhouse-Olson. (2017) Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and In Vitro Efficacy Analysis. Neoplasia 19:9, pages 716-733.
Crossref
Oleg Kurtenkov & Kersti Klaamas. (2017) Hidden IgG Antibodies to the Tumor-Associated Thomsen-Friedenreich Antigen in Gastric Cancer Patients: Lectin Reactivity, Avidity, and Clinical Relevance. BioMed Research International 2017, pages 1-11.
Crossref
P. Ulsemer, K. Toutounian, G. Kressel, C. Goletz, J. Schmidt, U. Karsten, A. Hahn & S. Goletz. (2016) Impact of oral consumption of heat-treated Bacteroides xylanisolvens DSM 23964 on the level of natural TFα-specific antibodies in human adults . Beneficial Microbes 7:4, pages 485-500.
Crossref
Jing-Zhang Wang, Yu-Hua Zhang, Xin-Hua Guo, Hong-Yan Zhang & Yuan Zhang. (2016) The double-edge role of B cells in mediating antitumor T-cell immunity: Pharmacological strategies for cancer immunotherapy. International Immunopharmacology 36, pages 73-85.
Crossref
Simone Werner, Hongda Chen, Sha Tao & Hermann Brenner. (2014) Systematic review: Serum autoantibodies in the early detection of gastric cancer. International Journal of Cancer 136:10, pages 2243-2252.
Crossref
Yaron Carmi, Matthew H. Spitzer, Ian L. Linde, Bryan M. Burt, Tyler R. Prestwood, Nicola Perlman, Matthew G. Davidson, Justin A. Kenkel, Ehud Segal, Ganesh V. Pusapati, Nupur Bhattacharya & Edgar G. Engleman. (2015) Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity. Nature 521:7550, pages 99-104.
Crossref
Zane Kalniņa. (2015) Emerging blood-based biomarkers for detection of gastric cancer. World Journal of Gastroenterology 21:41, pages 11636.
Crossref
Oleg Kurtenkov & Kersti Klaamas. (2015) Increased Avidity of the Sambucus nigra Lectin-Reactive Antibodies to the Thomsen-Friedenreich Antigen as a Potential Biomarker for Gastric Cancer . Disease Markers 2015, pages 1-8.
Crossref
A.H. Mansour, Mohammed Amin Mohammed, Rokia Anwar, M.E. Elzafrany & Nesreen Moustafa Omar. (2014) ABO Blood Group and Risk of Malignancies in Egyptians. International Journal of Cancer Research 10:2, pages 81-95.
Crossref
Johannes W. Pedersen, Aleksandra Gentry‐Maharaj, Alexander Nøstdal, Evangelia‐Ourania Fourkala, Anne Dawnay, Matthew Burnell, Alexey Zaikin, Joy Burchell, Joyce Taylor Papadimitriou, Henrik Clausen, Ian Jacobs, Usha Menon & Hans H. Wandall. (2013) Cancer‐associated autoantibodies to MUC1 and MUC4—A blinded case–control study of colorectal cancer in UK collaborative trial of ovarian cancer screening. International Journal of Cancer 134:9, pages 2180-2188.
Crossref
Oleg Kurtenkov, Jelena Izotova, Kersti Klaamas & Boris Sergeyev. (2014) Increased Sialylation of Anti-Thomsen-Friedenreich Antigen (CD176) Antibodies in Patients with Gastric Cancer: A Diagnostic and Prognostic Potential. BioMed Research International 2014, pages 1-11.
Crossref
Behjatolah Monzavi-Karbassi, Anastas Pashov & Thomas Kieber-Emmons. (2013) Tumor-Associated Glycans and Immune Surveillance. Vaccines 1:2, pages 174-203.
Crossref
Philippe Ulsemer, Gemma Henderson, Kawe Toutounian, Anja Löffler, Jens Schmidt, Uwe Karsten, Michael Blaut & Steffen Goletz. (2013) Specific humoral immune response to the Thomsen-Friedenreich tumor antigen (CD176) in mice after vaccination with the commensal bacterium Bacteroides ovatus D-6. Cancer Immunology, Immunotherapy 62:5, pages 875-887.
Crossref
Kristel Kodar, Johannes Stadlmann, Kersti Klaamas, Boris Sergeyev & Oleg Kurtenkov. (2011) Immunoglobulin G Fc N-glycan profiling in patients with gastric cancer by LC-ESI-MS: relation to tumor progression and survival. Glycoconjugate Journal 29:1, pages 57-66.
Crossref
Hannah Barrow, Xiuli Guo, Hans H. Wandall, Johannes W. Pedersen, Bo Fu, Qicheng Zhao, Chen Chen, Jonathan M. Rhodes & Lu-Gang Yu. (2011) Serum Galectin-2, -4, and -8 Are Greatly Increased in Colon and Breast Cancer Patients and Promote Cancer Cell Adhesion to Blood Vascular Endothelium. Clinical Cancer Research 17:22, pages 7035-7046.
Crossref
Jamie Heimburg-Molinaro, Michelle Lum, Geraldine Vijay, Miten Jain, Adel Almogren & Kate Rittenhouse-Olson. (2011) Cancer vaccines and carbohydrate epitopes. Vaccine 29:48, pages 8802-8826.
Crossref
G. Henderson, P. Ulsemer, U. Schober, A. Loffler, C.-A. Alpert, M. Zimmermann-Kordmann, W. Reutter, U. Karsten, S. Goletz & M. Blaut. (2011) Occurrence of the human tumor-specific antigen structure Gal 1-3GalNAc - (Thomsen-Friedenreich) and related structures on gut bacteria: Prevalence, immunochemical analysis and structural confirmation. Glycobiology 21:10, pages 1277-1289.
Crossref
Silvia Von Mensdorff-Pouilly, Maria Moreno & René H. M. Verheijen. (2011) Natural and Induced Humoral Responses to MUC1. Cancers 3:3, pages 3073-3103.
Crossref
Holger Thie, Lars Toleikis, Jiandong Li, Reinhard von Wasielewski, Gunther Bastert, Thomas Schirrmann, Isabel Tourais Esteves, Christian K. Behrens, Bénédict Fournes, Nathalie Fournier, Christophe de Romeuf, Michael Hust & Stefan Dübel. (2011) Rise and Fall of an Anti-MUC1 Specific Antibody. PLoS ONE 6:1, pages e15921.
Crossref
Sebastian Kobold, Tim Lütkens, Yanran Cao, Carsten Bokemeyer & Djordje Atanackovic. (2010) Autoantibodies against tumor-related antigens: Incidence and biologic significance. Human Immunology 71:7, pages 643-651.
Crossref
Nita Amornsiripanitch, Shaolin Hong, Michael J. Campa, Michael M. Frank, Elizabeth B. Gottlin & Edward F. PatzJr.Jr.. (2010) Complement Factor H Autoantibodies Are Associated with Early Stage NSCLC. Clinical Cancer Research 16:12, pages 3226-3231.
Crossref
Anastas Pashov, Bejatolah Monzavi-Karbassi, Gajendra P. S. Raghava & Thomas Kieber-Emmons. (2010) Bridging Innate and Adaptive Antitumor Immunity Targeting Glycans. Journal of Biomedicine and Biotechnology 2010, pages 1-19.
Crossref
Miriam Reuschenbach, Magnus von Knebel Doeberitz & Nicolas Wentzensen. (2009) A systematic review of humoral immune responses against tumor antigens. Cancer Immunology, Immunotherapy 58:10, pages 1535-1544.
Crossref
Qicheng Zhao, Xiuli Guo, Gerard B. Nash, Philip C. Stone, John Hilkens, Jonathan M. Rhodes & Lu-Gang Yu. (2009) Circulating Galectin-3 Promotes Metastasis by Modifying MUC1 Localization on Cancer Cell Surface. Cancer Research 69:17, pages 6799-6806.
Crossref
Janardan P. Pandey, Paul J. Nietert, Silvia von Mensdorff-Pouilly, Kersti Klaamas & Oleg Kurtenkov. (2008) Immunoglobulin Allotypes Influence Antibody Responses to Mucin 1 in Patients with Gastric Cancer. Cancer Research 68:11, pages 4442-4446.
Crossref
Eugeniy P Smorodin, Oleg A Kurtenkov, Boris L Sergeyev, Kristel E Kodar, Valentin I Chuzmarov & Vladimir P Afanasyev. (2008) Postoperative change of anti-Thomsen-Friedenreich and Tn IgG level: The follow-up study of gastrointestinal cancer patients. World Journal of Gastroenterology 14:27, pages 4352.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.